Division of Nephrology, Hypertension & Pheresis

Medicine & Life Sciences

1. Kidney 100%
2. Pediatrics 68%
3. Transplants 61%
4. Parathyroid Hormone 53%
5. Chronic Renal Insufficiency 51%
6. Kidney Transplantation 50%
7. Transplant Recipients 37%
8. Child 37%
9. Chronic Kidney Disease-Mineral and Bone Disorder 33%
10. Osteoclasts 33%
11. Vascular Calcification 31%
12. Calcium 28%
13. Lymphoproliferative Disorders 26%
14. Osteoblasts 23%
15. Phosphates 23%
16. Chronic Kidney Failure 22%
17. Bone and Bones 22%
18. Bone Morphogenetic Protein 7 22%
19. Nephrology 22%
20. Osteopontin 19%
21. Allografts 17%
22. Registries 17%
23. Renal Dialysis 16%
24. Immunosuppression 16%
25. Calcitriol 16%
26. Dialysis 15%
27. Kidney Diseases 14%
28. Blood Vessels 14%
29. Continuous Renal Replacement Therapy 14%
30. Serum 13%
31. Acute Kidney Injury 13%
32. BK Virus 13%
33. Therapeutics 13%
34. Membranes 12%
35. Phosphorus 12%
36. Hypertension 12%
37. Bone Resorption 12%
38. Proteins 12%
39. Microvilli 12%
40. Hyperphosphatemia 11%
41. Glomerular Filtration Rate 11%
42. Vitamin D 11%
43. Tissue Donors 11%
44. Integrins 11%
45. Organ Transplantation 10%
46. Creatinine 10%
47. Transplantation 10%
48. Urine 10%
49. Osteogenesis 10%
50. African Americans 10%
51. Steroids 9%
52. Wounds and Injuries 9%
53. Podosomes 9%
54. Infections 9%
55. Phenotype 9%
56. Dogs 9%
57. Minerals 9%
58. Blood Pressure 9%
59. Mortality 9%
60. Graft Survival 8%
61. Lupus Nephritis 8%
62. thymoglobulin 8%
63. Heart 8%
64. Nephrotic Syndrome 8%
65. Gelsolin 8%
66. Genes 8%
67. Biomarkers 7%
68. Mutation 7%
69. Secondary Hyperparathyroidism 7%
70. Cystatin C 7%
71. Human Herpesvirus 4 7%
72. Bone Density 7%
73. Atherosclerotic Plaques 7%
74. Arteriovenous Fistula 7%
75. Survival 7%
76. Renal Insufficiency 7%
77. Young Adult 7%
78. Medicare 7%
79. Elastin 7%
80. fibroblast growth factor 23 7%
81. Osteosarcoma 7%
82. Biopsy 7%
83. Canidae 6%
84. Bone Remodeling 6%
85. Peritoneal Dialysis 6%
86. Cell Membrane 6%
87. Tacrolimus 6%
88. Incidence 6%
89. Inositol 6%
90. Uremia 6%
91. Cantu syndrome 6%
92. Population 5%
93. Fibrosis 5%
94. Antibodies 5%
95. Vascular Smooth Muscle 5%
96. activin receptor type II-A 5%
97. Urinary Tract Infections 5%
98. Medication Adherence 5%
99. Nephrolithiasis 5%
100. Phosphatidylinositols 5%